Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES PHARMA SCIENCE   ADCOCK INGRAM
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-23
ADCOCK INGRAM
Jun-14
STRIDES PHARMA SCIENCE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs392314-   
Low Rs263226-   
Sales per share (Unadj.) Rs408.593.4-  
Earnings per share (Unadj.) Rs-25.6-23.5-  
Cash flow per share (Unadj.) Rs1.4-19.5-  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs242.873.3-  
Shares outstanding (eoy) m90.30168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.82.9 27.7%   
Avg P/E ratio x-12.8-11.5 111.7%  
P/CF ratio (eoy) x239.6-13.9 -1,729.6%  
Price / Book Value ratio x1.43.7 36.6%  
Dividend payout %-5.90-   
Avg Mkt Cap Rs m29,60345,603 64.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7,3202,862 255.8%   
Avg. sales/employee Rs Th03,671.4-  
Avg. wages/employee Rs Th0666.7-  
Avg. net profit/employee Rs Th0-925.1-  
INCOME DATA
Net Sales Rs m36,88415,761 234.0%  
Other income Rs m1,352110 1,225.1%   
Total revenues Rs m38,23615,872 240.9%   
Gross profit Rs m830-2,731 -30.4%  
Depreciation Rs m2,433680 357.6%   
Interest Rs m2,611427 611.7%   
Profit before tax Rs m-2,862-3,728 76.8%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-553233 -237.4%   
Profit after tax Rs m-2,309-3,971 58.1%  
Gross profit margin %2.2-17.3 -13.0%  
Effective tax rate %19.3-6.2 -309.2%   
Net profit margin %-6.3-25.2 24.8%  
BALANCE SHEET DATA
Current assets Rs m31,35311,544 271.6%   
Current liabilities Rs m29,9026,495 460.4%   
Net working cap to sales %3.932.0 12.3%  
Current ratio x1.01.8 59.0%  
Inventory Days Days71111 64.1%  
Debtors Days Days129124 103.8%  
Net fixed assets Rs m31,3006,729 465.2%   
Share capital Rs m90373 1,234.0%   
"Free" reserves Rs m21,0250-   
Net worth Rs m21,92812,371 177.3%   
Long term debt Rs m11,3984,347 262.2%   
Total assets Rs m63,73423,369 272.7%  
Interest coverage x-0.1-7.7 1.2%   
Debt to equity ratio x0.50.4 147.9%  
Sales to assets ratio x0.60.7 85.8%   
Return on assets %0.5-15.2 -3.1%  
Return on equity %-10.5-32.1 32.8%  
Return on capital %-0.8-19.8 3.8%  
Exports to sales %46.70-   
Imports to sales %00-   
Net fx Rs m17,4420-   
CASH FLOW
From Operations Rs m4441,345 33.0%  
From Investments Rs m3,025-413 -732.2%  
From Financial Activity Rs m-2,1393,945 -54.2%  
Net Cashflow Rs m1,3284,878 27.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.33 Rs / ZAR

Compare STRIDES PHARMA SCIENCE With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare STRIDES PHARMA SCIENCE With: MANGALAM DRUGS  GUJ.TERC LAB  BANDARAM PHARMA PACKTECH  JAGSON PHAR  PFIZER  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.